Author Archives: Natalie Themm
Dan Lundergan named CEO of University of Utah Health hospitals and clinics
Dan Lundergan, MHA, COO at University of Utah Health Hospitals and Clinics, has been appointed to the role of CEO. He has served as interim CEO since February and steps into the official role beginning immediately.
BlueWind Medical enrolls 100th patient in OASIS study of Renova iStim system
BlueWind Medical has announced that the 100th patient has been enrolled in its OASIS (Overactive bladder stimulation system) study—a clinical pivotal trial designed to test the safety and efficacy of the Renova iStim system in providing tibial neuromodulation (TNM) therapy.
Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy
Peer-reviewed results describe the Company’s test being used to confirm the presence of the virus on community waste, including mutated strains
U.S. Rep. Burgess Owens Spends a Day in the BioHive
On Monday, U.S. Rep. Burgess Owens (R-UT-4) spent the day visiting a number of life sciences companies – Owlet, Spectrum Solutions, Merit Medical, Matia Robotics and ARUP Laboratories.
Mountain Pacific Announces New Funding Opportunities
Ron Heffernan, Managing Partner at Mountain Pacific Partners recently announced the launch of Mountain Pacific’s newest funds.
PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer
World-renowned neurologist and movement disorders specialist joins PhotoPharmics as company advances breakthrough device through pivotal clinical trial and to commercialization.
Renalytix Appoints Daniel J. Levangie to its Board of Directors
Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic.
Mountain Pacific Partners Invests $2M in Growth Capital into Alterra Medical
Salt Lake City-based specialty medical device distributor is poised for value-creating diversification and supply chain innovation.
Alterra Medical Announces Jeff Hastings as New Chief Executive Officer
With more than two decades of healthcare expertise, Hastings brings track record of leading transformative growth.
ARUP’s Investment Will Help Boost Development of Techcyte’s AI-Enabled Diagnostics Platform
ARUP Laboratories recently announced an investment in Techcyte Inc. as part of the Orem, Utah-based company’s new $21 million funding round.
ANNUAL BIOUTAH AWARDS
Nominations are now open for BioUtah’s 2021 awards. The deadline for nominations is September 18.
KNOWN MEDICINE RAISES $7.2 MILLION SEED ROUND TO ADVANCE DATA FIRST APPROACH TO ORGANOID TECHNOLOGY
Known Medicine today announced the closure of its seed round of funding in the amount of $7.2 million led by Caffeinated Capital, with participation from Khosla Ventures, Cota Capital, Kickstart, Forward VC, OATV, Y Combinator and noted angel investors Chris Gibson, CEO & Co-Founder at Recursion Pharmaceuticals, Nish Bhat, previously Co-Founder at Color Genomics, and others.
